These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29387344)

  • 21. Acinetobacter lwoffii an emerging pathogen in neonatal ICU.
    Mittal S; Sharma M; Yadav A; Bala K; Chaudhary U
    Infect Disord Drug Targets; 2015; 15(3):184-8. PubMed ID: 26307173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.
    Ventura RF; Galdino ACM; Viganor L; Schuenck RP; Devereux M; McCann M; Santos ALS; Nunes APF
    Braz J Microbiol; 2020 Dec; 51(4):1703-1710. PubMed ID: 32737867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates.
    Rubio T; Gagné S; Debruyne C; Dias C; Cluzel C; Mongellaz D; Rousselle P; Göttig S; Seifert H; Higgins PG; Salcedo SP
    mSystems; 2022 Feb; 7(1):e0048821. PubMed ID: 35103489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
    Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to tigecycline of Acinetobacter baumannii strains isolated from intensive care unit patients.
    Talaga K; Krzyściak P; Bulanda M
    Anaesthesiol Intensive Ther; 2016; 48(3):166-70. PubMed ID: 27013253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.
    Boone RL; Whitehead B; Avery TM; Lu J; Francis JD; Guevara MA; Moore RE; Chambers SA; Doster RS; Manning SD; Townsend SD; Dent L; Marshall D; Gaddy JA; Damo SM
    BMC Microbiol; 2021 Jan; 21(1):21. PubMed ID: 33422000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug resistance analysis of pan-drug-resistant Acinetobacter baumannii in hospital].
    Sun CD; Li Z; Liu S; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jun; 25(6):369-72. PubMed ID: 23739573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates.
    Souli M; Galani I; Plachouras D; Panagea T; Armaganidis A; Petrikkos G; Giamarellou H
    J Antimicrob Chemother; 2013 Apr; 68(4):852-7. PubMed ID: 23228934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital.
    Gong Y; Shen X; Huang G; Zhang C; Luo X; Yin S; Wang J; Hu F; Peng Y; Li M
    J Microbiol; 2016 Aug; 54(8):551-8. PubMed ID: 27480635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activity of copper and niobium-alloyed austenitic stainless steel.
    Baena MI; Márquez MC; Matres V; Botella J; Ventosa A
    Curr Microbiol; 2006 Dec; 53(6):491-5. PubMed ID: 17072670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.
    Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M
    J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Laboratory Research to a Clinical Trial: Copper Alloy Surfaces Kill Bacteria and Reduce Hospital-Acquired Infections.
    Michels HT; Keevil CW; Salgado CD; Schmidt MG
    HERD; 2015; 9(1):64-79. PubMed ID: 26163568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.